215 related articles for article (PubMed ID: 10595458)
21. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
Endo K; Ueda T; Ueyama J; Ohta T; Terada T
Hum Pathol; 2000 May; 31(5):558-65. PubMed ID: 10836294
[TBL] [Abstract][Full Text] [Related]
22. Modulation of cadherin and catenins expression by tumor necrosis factor-alpha and dexamethasone in human bronchial epithelial cells.
Carayol N; Campbell A; Vachier I; Mainprice B; Bousquet J; Godard P; Chanez P
Am J Respir Cell Mol Biol; 2002 Mar; 26(3):341-7. PubMed ID: 11867342
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.
Shimazui T; Schalken JA; Giroldi LA; Jansen CF; Akaza H; Koiso K; Debruyne FM; Bringuier PP
Cancer Res; 1996 Sep; 56(18):4154-8. PubMed ID: 8797585
[TBL] [Abstract][Full Text] [Related]
24. Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer.
Syrigos KN; Harrington K; Waxman J; Krausz T; Pignatelli M
J Urol; 1998 Nov; 160(5):1889-93. PubMed ID: 9783980
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
26. Expression of e-cadherin and catenins in early gastric cancer.
Joo YE; Rew JS; Choi SK; Bom HS; Park CS; Kim SJ
J Clin Gastroenterol; 2002 Jul; 35(1):35-42. PubMed ID: 12080224
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of E-cadherin, alpha- and beta-catenins in papillary thyroid carcinoma.
Kapran Y; Ozbey N; Molvalilar S; Sencer E; Dizdaroğlu F; Ozarmağan S
J Endocrinol Invest; 2002; 25(7):578-85. PubMed ID: 12150330
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of E-cadherin and beta catenin in primary and metastatic Wilms's tumours.
Alami J; Williams BR; Yeger H
Mol Pathol; 2003 Aug; 56(4):218-25. PubMed ID: 12890743
[TBL] [Abstract][Full Text] [Related]
29. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions.
Nakanishi Y; Ochiai A; Akimoto S; Kato H; Watanabe H; Tachimori Y; Yamamoto S; Hirohashi S
Oncology; 1997; 54(2):158-65. PubMed ID: 9075789
[TBL] [Abstract][Full Text] [Related]
30. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival.
Jawhari A; Jordan S; Poole S; Browne P; Pignatelli M; Farthing MJ
Gastroenterology; 1997 Jan; 112(1):46-54. PubMed ID: 8978342
[TBL] [Abstract][Full Text] [Related]
31. [Correlation of E-cadherin, beta-catenin and gamma-catenin gene expression with the invasion and metastasis of gastric carcinoma].
Wang CX; Chen J; Yang Z; Song W; Du ZL; Li ZH
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1198-201. PubMed ID: 14625188
[TBL] [Abstract][Full Text] [Related]
32. The expression of E-cadherin and catenins in sporadic colorectal carcinoma.
El-Bahrawy MA; Poulsom R; Jeffery R; Talbot I; Alison MR
Hum Pathol; 2001 Nov; 32(11):1216-24. PubMed ID: 11727261
[TBL] [Abstract][Full Text] [Related]
33. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
[TBL] [Abstract][Full Text] [Related]
34. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V
J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863
[TBL] [Abstract][Full Text] [Related]
35. Expression of cadherins and their undercoat proteins (alpha-, beta-, and gamma-catenins and p120) and accumulation of beta-catenin with no gene mutations in synovial sarcoma.
Sato H; Hasegawa T; Kanai Y; Tsutsumi Y; Osamura Y; Abe Y; Sakai H; Hirohashi S
Virchows Arch; 2001 Jan; 438(1):23-30. PubMed ID: 11213832
[TBL] [Abstract][Full Text] [Related]
36. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
[TBL] [Abstract][Full Text] [Related]
37. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
[TBL] [Abstract][Full Text] [Related]
38. E-, N- and P-cadherin, and alpha-, beta- and gamma-catenin protein expression in normal, hyperplastic and carcinomatous human prostate.
Arenas MI; Romo E; Royuela M; Fraile B; Paniagua R
Histochem J; 2000 Nov; 32(11):659-67. PubMed ID: 11272805
[TBL] [Abstract][Full Text] [Related]
39. Cadherin-catenin complex: protein interactions and their implications for cadherin function.
Aberle H; Schwartz H; Kemler R
J Cell Biochem; 1996 Jun; 61(4):514-23. PubMed ID: 8806074
[TBL] [Abstract][Full Text] [Related]
40. Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines.
Noda M; Tatsumi Y; Tomizawa M; Takama T; Mitsufuji S; Sugihara H; Kashima K; Hattori T
J Gastroenterol; 2002; 37(11):896-904. PubMed ID: 12483244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
